352 related articles for article (PubMed ID: 25920434)
1. Leiomyosarcoma: One disease or distinct biologic entities based on site of origin?
Worhunsky DJ; Gupta M; Gholami S; Tran TB; Ganjoo KN; van de Rijn M; Visser BC; Norton JA; Poultsides GA
J Surg Oncol; 2015 Jun; 111(7):808-12. PubMed ID: 25920434
[TBL] [Abstract][Full Text] [Related]
2. The influence of primary site on outcomes in leiomyosarcoma: a review of clinicopathologic differences between uterine and extrauterine disease.
Farid M; Ong WS; Tan MH; Foo LS; Lim YK; Chia WK; Soh LT; Poon D; Lee MJ; Ho ZC; Jeevan R; Chin F; Teo M; Quek R
Am J Clin Oncol; 2013 Aug; 36(4):368-74. PubMed ID: 22772425
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection for recurrent retroperitoneal leiomyosarcoma and liposarcoma.
Nathenson MJ; Barysauskas CM; Nathenson RA; Regine WF; Hanna N; Sausville E
World J Surg Oncol; 2018 Oct; 16(1):203. PubMed ID: 30309356
[TBL] [Abstract][Full Text] [Related]
4. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma.
Giuntoli RL; Garrett-Mayer E; Bristow RE; Gostout BS
Gynecol Oncol; 2007 Jul; 106(1):82-8. PubMed ID: 17434579
[TBL] [Abstract][Full Text] [Related]
5. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
[TBL] [Abstract][Full Text] [Related]
6. Comparison of current staging systems and a novel staging system for uterine leiomyosarcoma.
Giuntoli RL; Lessard-Anderson CR; Gerardi MA; Kushnir CL; Cliby WA; Metzinger DS; Gostout BS
Int J Gynecol Cancer; 2013 Jun; 23(5):869-76. PubMed ID: 23669444
[TBL] [Abstract][Full Text] [Related]
7. Leiomyosarcoma: investigation of prognostic factors for risk-stratification model.
Kim HJ; Cho YJ; Kim SH; Rha SY; Ahn JB; Yang WI; Lee YH; Suh JS; Roh JK; Kim KS; Choi YD; Shin KH; Kim HS
Int J Clin Oncol; 2015 Dec; 20(6):1226-32. PubMed ID: 26123311
[TBL] [Abstract][Full Text] [Related]
8. The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
Park JY; Park SK; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Gynecol Oncol; 2011 Aug; 122(2):255-9. PubMed ID: 21565389
[TBL] [Abstract][Full Text] [Related]
9. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy.
Smith R; Pak Y; Kraybill W; Kane JM
Eur J Surg Oncol; 2009 Apr; 35(4):356-61. PubMed ID: 18294807
[TBL] [Abstract][Full Text] [Related]
10. Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma.
Leitao MM; Brennan MF; Hensley M; Sonoda Y; Hummer A; Bhaskaran D; Venkatraman E; Alektiar K; Barakat RR
Gynecol Oncol; 2002 Dec; 87(3):287-94. PubMed ID: 12468327
[TBL] [Abstract][Full Text] [Related]
11. The role of fibroblast growth factor 2 in patients with uterine smooth muscle tumors: an immunohistochemical study.
Bodner-Adler B; Mayerhofer K; Czerwenka K; Kimberger O; Koelbl H; Bodner K
Eur J Obstet Gynecol Reprod Biol; 2016 Dec; 207():62-67. PubMed ID: 27825029
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for recurrence and survival in patients with primary retroperitoneal tumors.
Li B; Luo CH; Zheng W
J BUON; 2013; 18(3):782-7. PubMed ID: 24065499
[TBL] [Abstract][Full Text] [Related]
13. A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma Collaborative.
Lee RM; Ethun CG; Zaidi MY; Tran TB; Poultsides GA; Grignol VP; Howard JH; Bedi M; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Oskouei SV; Monson DK; Reimer NB; Maithel SK; Cardona K
Surg Oncol; 2020 Sep; 34():292-297. PubMed ID: 32891345
[TBL] [Abstract][Full Text] [Related]
14. Predictors of survival and recurrence in primary leiomyosarcoma.
Gladdy RA; Qin LX; Moraco N; Agaram NP; Brennan MF; Singer S
Ann Surg Oncol; 2013 Jun; 20(6):1851-7. PubMed ID: 23354568
[TBL] [Abstract][Full Text] [Related]
15. [Predictors of local recurrence and survival in primary retroperitoneal leiomyosarcoma].
Chen G; Yan Y; Xiao C; Sun P; Xue H; Li R
Zhonghua Wai Ke Za Zhi; 2014 Feb; 52(2):105-8. PubMed ID: 24809517
[TBL] [Abstract][Full Text] [Related]
16. Leiomyosarcoma and sarcoma with myogenic differentiation: two different entities or 2 faces of the same disease?
Colombo C; Miceli R; Collini P; Radaelli S; Palassini E; Stacchiotti S; Fiore M; Mariani L; Casali PG; Gronchi A
Cancer; 2012 Nov; 118(21):5349-57. PubMed ID: 22517186
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous core needle biopsy in retroperitoneal sarcomas does not influence local recurrence or overall survival.
Wilkinson MJ; Martin JL; Khan AA; Hayes AJ; Thomas JM; Strauss DC
Ann Surg Oncol; 2015 Mar; 22(3):853-8. PubMed ID: 25190132
[TBL] [Abstract][Full Text] [Related]
18. Uterine Sarcoma: Clinical Presentation, Treatment and Survival Outcomes in Thailand.
Potikul C; Tangjitgamol S; Khunnarong J; Srijaipracharoen S; Thavaramara T; Pataradool K
Asian Pac J Cancer Prev; 2016; 17(4):1759-67. PubMed ID: 27221849
[TBL] [Abstract][Full Text] [Related]
19. Leiomyosarcoma of the skin: clinical, histopathologic, and prognostic factors that influence outcomes.
Winchester DS; Hocker TL; Brewer JD; Baum CL; Hochwalt PC; Arpey CJ; Otley CC; Roenigk RK
J Am Acad Dermatol; 2014 Nov; 71(5):919-25. PubMed ID: 25174541
[TBL] [Abstract][Full Text] [Related]
20. Leiomyosarcoma: a 45-year review at Charity Hospital, New Orleans.
Hill MA; Mera R; Levine EA
Am Surg; 1998 Jan; 64(1):53-60; discussion 60-1. PubMed ID: 9457038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
